tradingkey.logo

Enovis Corp

ENOV
View Detailed Chart

26.280USD

-4.580-14.84%
Close 07/18, 16:00ETQuotes delayed by 15 min
1.50BMarket Cap
LossP/E TTM

Enovis Corp

26.280

-4.580-14.84%
Intraday
1m
30m
1h
D
W
M
D

Today

-14.84%

5 Days

-22.77%

1 Month

-14.29%

6 Months

-43.64%

Year to Date

-40.11%

1 Year

-43.99%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 11 analysts
BUY
Current Rating
58.444
Target Price
89.39%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

115
Total
6
Median
9
Average
Company name
Ratings
Analysts
Enovis Corp
ENOV
11
Medtronic PLC
MDT
34
Stryker Corp
SYK
33
Zimmer Biomet Holdings Inc
ZBH
31
Abbott Laboratories
ABT
29
Dexcom Inc
DXCM
28
1
2
3
...
23

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

1m
15m
30m
1h
D
W
M
1m
15m
30m
D
Sell
Sell(10)
Neutral(0)
Buy(0)
Indicators
Sell(4)
Neutral(0)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
-1.191
Sell
RSI(14)
29.658
Sell
STOCH(KDJ)(9,3,3)
9.710
Oversold
ATR(14)
1.805
High Vlolatility
CCI(14)
-189.387
Sell
Williams %R
97.320
Oversold
TRIX(12,20)
0.004
Sell
StochRSI(14)
0.000
Oversold
Moving Average
Sell(6)
Neutral(0)
Buy(0)
Indicators
Value
Direction
MA5
30.110
Sell
MA10
32.384
Sell
MA20
32.176
Sell
MA50
32.695
Sell
MA100
34.316
Sell
MA200
39.371
Sell

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing high-quality medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative diseases. The Prevention & Recovery products are marketed under several brand names, such as DJO. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. It also operates a Enovis Growth eXcellence business system (EGX).
Ticker SymbolENOV
CompanyEnovis Corp
CEOMr. Damien Mcdonald
Websitehttps://www.enovis.com/
KeyAI